Alexander S Korb1, Aimee M Hunter, Ian A Cook, Andrew F Leuchter. 1. Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior at UCLA, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1759, USA. alexkorb@ucla.edu
Abstract
OBJECTIVE: To assess whether pretreatment theta current density in the rostral anterior cingulate (rACC) and medial orbitofrontal cortex (mOFC) differentiates responders from non-responders to antidepressant medication or placebo in a double-blinded study. METHODS: Pretreatment EEGs were collected from 72 subjects with Major Depressive Disorder (MDD) who participated in one of three placebo-controlled trials. Subjects were randomized to receive treatment with fluoxetine, venlafaxine, or placebo. Low-resolution brain electromagnetic tomography (LORETA) was used to assess theta current density in the rACC and mOFC. RESULTS: Medication responders showed elevated rACC and mOFC theta current density compared to medication non-responders (rACC: p=0.042; mOFC: p=0.039). There was no significant difference in either brain region between placebo responders and placebo non-responders. CONCLUSIONS: Theta current density in the rACC and mOFC may be useful as a biomarker for prediction of response to antidepressant medication. SIGNIFICANCE: This is the first double-blinded treatment study to examine pretreatment rACC and mOFC theta current density in relation to antidepressant response and placebo response. Results support the potential clinical utility of this approach for predicting clinical outcome to antidepressant treatments in MDD.
RCT Entities:
OBJECTIVE: To assess whether pretreatment theta current density in the rostral anterior cingulate (rACC) and medial orbitofrontal cortex (mOFC) differentiates responders from non-responders to antidepressant medication or placebo in a double-blinded study. METHODS: Pretreatment EEGs were collected from 72 subjects with Major Depressive Disorder (MDD) who participated in one of three placebo-controlled trials. Subjects were randomized to receive treatment with fluoxetine, venlafaxine, or placebo. Low-resolution brain electromagnetic tomography (LORETA) was used to assess theta current density in the rACC and mOFC. RESULTS: Medication responders showed elevated rACC and mOFC theta current density compared to medication non-responders (rACC: p=0.042; mOFC: p=0.039). There was no significant difference in either brain region between placebo responders and placebo non-responders. CONCLUSIONS: Theta current density in the rACC and mOFC may be useful as a biomarker for prediction of response to antidepressant medication. SIGNIFICANCE: This is the first double-blinded treatment study to examine pretreatment rACC and mOFC theta current density in relation to antidepressant response and placebo response. Results support the potential clinical utility of this approach for predicting clinical outcome to antidepressant treatments in MDD.
Authors: V L Towle; J Bolaños; D Suarez; K Tan; R Grzeszczuk; D N Levin; R Cakmur; S A Frank; J P Spire Journal: Electroencephalogr Clin Neurophysiol Date: 1993-01
Authors: H S Mayberg; S K Brannan; R K Mahurin; P A Jerabek; J S Brickman; J L Tekell; J A Silva; S McGinnis; T G Glass; C C Martin; P T Fox Journal: Neuroreport Date: 1997-03-03 Impact factor: 1.837
Authors: Andrew F Leuchter; Melinda Morgan; Ian A Cook; Jennifer Dunkin; Michelle Abrams; Elise Witte Journal: Psychopharmacology (Berl) Date: 2004-07-14 Impact factor: 4.530
Authors: C E Tenke; J Kayser; L Miller; V Warner; P Wickramaratne; M M Weissman; G E Bruder Journal: Biol Psychol Date: 2013-08-30 Impact factor: 3.251
Authors: Craig E Tenke; Jürgen Kayser; Pia Pechtel; Christian A Webb; Daniel G Dillon; Franziska Goer; Laura Murray; Patricia Deldin; Benji T Kurian; Patrick J McGrath; Ramin Parsey; Madhukar Trivedi; Maurizio Fava; Myrna M Weissman; Melvin McInnis; Karen Abraham; Jorge E Alvarenga; Daniel M Alschuler; Crystal Cooper; Diego A Pizzagalli; Gerard E Bruder Journal: Psychophysiology Date: 2017-01 Impact factor: 4.016
Authors: Craig E Tenke; Jürgen Kayser; Jorge E Alvarenga; Karen S Abraham; Virginia Warner; Ardesheer Talati; Myrna M Weissman; Gerard E Bruder Journal: Clin Neurophysiol Date: 2018-04-16 Impact factor: 3.708
Authors: Alik S Widge; M Taha Bilge; Rebecca Montana; Weilynn Chang; Carolyn I Rodriguez; Thilo Deckersbach; Linda L Carpenter; Ned H Kalin; Charles B Nemeroff Journal: Am J Psychiatry Date: 2018-10-03 Impact factor: 18.112